Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News

December 4, 2014 — Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project ...

Home December 04, 2014
Home
AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab
Feature

November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...

Home November 24, 2014
Home
News

November 24, 2014 — Obesity is a known risk factor for atrial fibrillation (AFib), the most common heart rhythm disorder ...

Home November 24, 2014
Home
News

Nov. 5, 2014 — Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S ...

Home November 05, 2014
Home
News

October 30, 2014 — New physician experience for the Convergent Procedure in the treatment of persistent atrial ...

Home October 30, 2014
Home
Topera, Abbott, FIRMap, rotors, rotor mapping
Feature
Oct. 29, 2014 – Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device ...
Home October 29, 2014
Home
Technology

October 28, 2014 — St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval of its ...

Home October 28, 2014
Home
News

October 17, 2014 – The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and ...

Home October 17, 2014
Home
News

October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.

As of ...

Home October 15, 2014
Home
News

October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage ...

Home October 13, 2014
Home
Technology

September 29, 2014 — AliveCor announced the launch of the latest version of the AliveECG app, which provides patients ...

Home September 29, 2014
Home
Feature

September 26, 2014 — The American Association for Thoracic Surgery (AATS) has released new evidence-based guidelines for ...

Home September 26, 2014
Home
Technology

September 26, 2014 — AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible ...

Home September 26, 2014
Home
News

September 15, 2014 — A new gene-directed drug being tested through a research study called GENETIC-AF may improve care ...

Home September 15, 2014
Home
News

September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein ...

Home September 02, 2014
Home
Subscribe Now